Ty. Goraya et al., SIGNAL-TRANSDUCTION ALTERATIONS IN PERIPHERAL-NERVES FROM STREPTOZOTOCIN-INDUCED DIABETIC RATS, Journal of neuroscience research, 41(4), 1995, pp. 518-525
We have previously determined the presence of muscarinic receptors and
the expression of several G proteins in homogenates and myelin fracti
ons from rat sciatic nerves, In the present study we investigated whet
her changes in several signal transduction pathways in peripheral nerv
es might be responsible for some of the biochemical abnormalities (e,g
,, phosphoinositide metabolism) present in sciatic nerves from strepto
zotocin-induced diabetic rats, Sciatic nerves from 5 week diabetic rat
s that were prelabelled with [H-3]-myo-inositol displayed a significan
t increase in the basal release of inositol mono- and bis-phosphate, w
hile carbamylcholine-stimulated release was significantly smaller, Bas
al- and forskolin-stimulated adenylyl cyclase activity was significant
ly decreased in sciatic nerve homogenates from diabetic animals. Howev
er, we were unable to detect any significant differences in the levels
of cAMP in intact nerves or in nerve segments that were incubated in
the presence or absence of forskolin, ADP-ribosylation experiments sho
wed that in sciatic nerves from experimentally diabetic rats there was
a significant increase in the ADP-ribosylation catalyzed by cholera a
nd pertussis toxins, Measurements of the levels of alpha-subunits of G
proteins revealed that the expression of G(q/11)alpha, G(s) alpha, an
d G(i-3)alpha was increased by 30 to 50%, These results indicate that
during the course of experimental diabetes, peripheral nerves exhibit
an abnormal production of inositol phosphates and cAMP, together with
an abnormal expression and/or function of G proteins, One of the conse
quences of such alterations is the diminished release of inositol phos
phates triggered by muscarinic agonists in diabetic sciatic nerves. (C
) 1995 Wiley-Liss, Inc.